Home
Live Updates
FDA approves expanded MRI labeling for Abbott neurostim : comparemela.com
FDA approves expanded MRI labeling for Abbott neurostim
Abbott (NYSE: ABT) announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system.
Related Keywords
West Virginia ,
United States ,
Pedro Malha ,
Nerve Centers Of The Virginias ,
Timothy Deer ,
Nerve Centers ,
comparemela.com © 2020. All Rights Reserved.